difference between mounjaro and compounded tirzepatide vs regular tirzepatide: key differences Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

A large study conducted by the manufacturer of a leading GLP-1 medication found that people who discontinued semaglutide gained back an average of two-thirds of the weight they lost in just one year

Brand-name medications like Mounjaro and Zepbound are FDA-approved

3 There is a wide range of comorbidities associated with obesity, including increased risk of type 2 diabetes, certain cancers, hypertension, cardiovascular disease, and gallstones, as well as psychological and psychiatric issues

Maximum 23 Zyklen pro Jahr

A recent retrospective cohort also observed that, even in overweight patients without diabetes, the risk of primary open-angle glaucoma and ocular hypertension were significantly lower in the GLP-1RA group at both 3 and 5 years of follow-up (Vasu et al., 2025), suggesting the benefit of GLP-1RAs in the eye as an independent factor apart from blood glucose control